Managers
Options, a provider of cloud-enabled managed services to the global capital markets, has secured a significant growth investment from Abry Partners, a Boston-based sector focused private equity firm. The transaction will enable the firm’s executive team to significantly accelerate its growth strategy, pursue strategic M&A targets, invest further in the firm’s technology platform and expand Options’ reach in key financial centres globally. No further terms of the transaction were disclosed.
Options, founded in 1993 as a hedge fund technology services provider, has expanded rapidly in recent years and now finds itself as an established market leader in outsourced financial technology and managed
Funds managed by Northleaf Capital Partners (Northleaf) have acquired a 90 per cent stake in Douglas Terminals from Hartree Partners (UK) Limited (Hartree) and Ghent Transport & Storage NV (GTS).Douglas Terminals is a 557,000-cubic metre liquid bulk storage terminal based in the Port of Ghent, Belgium. The facility consists of 17 high-quality tanks currently used for the storage of jet fuel, gasoil, diesel and biodiesel. Hartree and GTS started commercial operations at the terminal in 2017. GTS will retain a 10 per cent stake and continue to operate the terminal under a management services agreement. As part of the transaction,
Varagon Capital Partners, a direct lender to middle market companies, is to form a new strategic partnership with Aflac Global Investments (Aflac) and is extending its existing strategic partnership with American International Group (AIG).Upon closing of the new partnership, Aflac will make a new multi-year investment commitment of up to USD3.0 billion to Varagon to invest in middle market loans. Aflac will also acquire a significant non-controlling minority interest in Varagon, creating a mutually-beneficial partnership and demonstrating a commitment to a long-term relationship.
Aflac will acquire the interests in Varagon currently held by certain former and current partners and
Edinburgh-based biotech startup MiAlgae has received an investment of GBP1 million to focus on the commercialisation of its revolutionary microalgae product, targeting the rapidly growing global aquaculture and pet food industries.The biotech business uses co-products from the whisky distillation process to produce microalgae, which is high in omega 3 and other nutrients. The algae can be used to sustainably feed fish and create animal food. MiAlgae estimates that one tonne of its algae saves up to 30 tonnes of wild fish.
MiAlgae will use the investment to double the size of its business premises, commission a demonstrator plant in East
Foresight Group (Foresight) and Williams Advanced Engineering (Williams) have launched a share offer for Foresight Williams Technology Shares, a new share class within Foresight Solar & Technology VCT. The Offer, which opened on 20 December 2019, has a target fundraise in aggregate of GBP20 million and is open to investors for tax years 2019/20 and 2020/2021.
The Foresight Williams Technology Share class represents an exciting investment opportunity made possible by the unique collaboration between Foresight and Williams Advanced Engineering (Williams) which saw the successful launch of the Foresight Williams Technology EIS Fund in 2016. It has thus far raised approximately GBP40
Novo Seeds’ portfolio company, NorthSea Therapeutics a Dutch biotech company developing novel and innovative strategies for the treatment of NASH (Non-alcoholic Steatohepatitis) and other metabolic, inflammatory and fibrotic diseases, has successfully closed a USD40 million (EUR36 million) Series B financing round.The proceeds of this fundraising will be used by NST to drive the development of its pipeline of SEFA (Structural Engineered Fatty Acids) programs. The Company will develop two additional SEFAs within its clinical pipeline in addition to completing the Phase 2b with its lead candidate Icosabutate.
In addition to Novo Seeds, existing investors, Forbion, New Science Ventures (NSV)
Shoreline Equity Partners, a purpose-driven lower middle market private equity firm, has held the final close of its inaugural private equity fund, Shoreline Equity Partners Fund. Shoreline began fundraising in March, in conjunction with the Firm’s launch, with an initial target of USD250 million and was oversubscribed at its hard cap of USD300 million in commitments.
“We are very grateful to all of our limited partners for the resounding support and humbled by the overwhelming demand shown through the process,” says the Firm’s Co-Founder Mike Hand. “The entire Shoreline team is excited to work closely with our portfolio company management teams
British MedTech business, OrganOx Ltd, has secured a GBP4.6 million investment from BGF, the UK and Ireland’s most active investor in growing businesses.The investment will fund commercial expansion of its first product, the metra, in the US, building on commercial traction in Europe, Canada and Australia.
OrganOx metra is the world’s first fully automated system for keeping a human donor liver functioning for up to 24 hours outside the body. The invention breaks with 40 years of traditional organ preservation in ice, doubling the time that donor organs can be preserved. The device mimics the environment of the human
Private equity firm Entrepreneurial Equity Partners’ (e2p) portfolio company, Daniele International, has completed a merger with Creminelli Fine Meats (Creminelli). Financial terms of the transaction have not been disclosed.Creminelli is a producer and distributor of premium charcuterie and protein snacks, known for exceptional quality and recognised with 11 national food awards. Creminelli’s product lines include charcuterie snack trays, deli trays, artisan salami, artisan deli, and salami minis. Creminelli’s approach of using ultra-premium ingredients and small-batch production was inherited from generations of Master Artisan Cristiano Creminelli’s family and has been maintained through the company’s rapid growth. Creminelli’s clean-label inputs and use of humanely
Iptor, a specialist in distribution and supply chain management, planning and logistics software and services, has been acquired by Bregal Unternehmerkapital alongside investment from current CEO Jayne Archbold and Chief Marketing and Product Officer Christopher Catterfeld. Bregal Unternehmerkapital is a growth-focused investment firm whose principal focus is to invest behind sound business models and strong leadership teams.
Iptor has been transformed over the past three years under the leadership of Archbold and Catterfeld. The re-branding and re-positioning of the business from IBS to Iptor has delivered exceptional progress, with the product portfolio having been transformed through the successful launch of the
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
